Top

22-01-2015 | Diabetic foot | Book chapter | Article

8. Endovascular Revascularisation: When and How

Authors: Andrew J. Wigham, BSc (Hons), MBBS, MRCS, FRCR, Raman Uberoi, BMSCPath, MBBchir, MRCP, FRCR

Publisher: Springer London

Abstract

Critical limb ischaemia in diabetic patients is associated with significant morbidity and mortality. The incidence of peripheral vascular disease is much higher amongst the diabetic population and associated diabetic neuropathy often means patients present late with ulceration and tissue loss. Management of the diabetic foot requires a multi-disciplinary team approach. Timely initiation of the appropriate investigations and treatment are vital to ensure optimal outcomes. Revascularisation can be performed with open bypass surgery or endovascular repair. There is increasing evidence to support endovascular treatment and with the gradual evolution of endovascular technologies it is now possible to effectively treat complex patterns of disease. In this chapter we will further explore the imaging assessment and the available endovascular treatment options in diabetic patients.

Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD): TASC working group: TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1–296.PubMedCrossRef

Graziani L, Silvestro A, Bertone V, Manara E, Andreini R, Sigala A, et al. Vascular involvement in diabetic subjects with ischaemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg. 2007;33:453–60.PubMedCrossRef

Norgren L, Hiatt WR, Dormandy JR, Nehler MR, Harris KA, Fowkes FG, on behalf of the TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45(Suppl S):S5–67.

Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: multicentre randomised controlled trial. Lancet. 2005;366(9501):1925–34.PubMedCrossRef

Soderstrom MI, Arvela EM, Korhonen M, Halmesmaki KH, Alback AN, Biancari F, et al. Infrapopliteal percutaneous transluminal angioplasty versus bypass surgery as first line strategies in critical limb ischaemia. A propensity score analysis. Ann Surg. 2010;252:765–73.PubMedCrossRef

LaMuraglia GM, Conrad MF, Chung T, Hutter M, Watkins MT, Cambria RP. Significant perioperative morbidity accompanies contemporary infrainguinal bypass surgery: an NSQIP report. J Vasc Surg. 2009;50(2):299–304.PubMedCrossRef

Laird JR, Katzen BT, Scheinery D, Lammer J, Carpenter J, Buchbinder M, et al. Nitinol stent implantation vs balloon angioplasty for lesions in the SFA and proximal popliteal arteries of patients with claudication: three year follow up from RESILIENT randomized trial. J Endovasc Ther. 2012;19(1):1–9.PubMedCrossRef

Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2 year follow up from the Zilver PTX randomized and single arm clinical studies. J Am Coll Cardiol. 2013;61(24):2417–27.PubMedCrossRef

Schmidt A, Piorkowski M, Werner M, Ulrich M, Bausback Y, Braunlich S, et al. First experience with drug eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol. 2011;58:1105–9.PubMedCrossRef

10.

Antoniou GA, Chalmers N, Kanesalingham K, Antoniou SA, Schiro A, Serracino-Inglott F, et al. Meta-analysis of outcomes of endovascular treatment of infrapopliteal occlusive disease with drug eluting stents. J Endovasc Ther. 2013;20(2):131–44.PubMedCrossRef

11.

Dick P, Barth B, Mlekusch W, Sabeti A, Amighi J, Schlager O, et al. Complications after peripheral vascular interventions in octogenarians. J Endovasc Ther. 2008;15:383–9.PubMedCrossRef

12.

Axisa B, Fishwick G, Bolia A, Thompson MM, London NJ, Bell PRF, Naylor R. Complications following peripheral angioplasty. Ann R Coll Surg Engl. 2002;84(1):39–42.PubMedCentralPubMed

Medicine Matters Diabetes

Abstract